Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. hospitalization rate
Show results for
Products
Services
Software

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Hospitalization Rate Articles & Analysis

36 news found

Daxor Corporation Announces Significant Expansion With Five Hospitals Implementing Its BVA-100 Blood Volume Diagnostic for Heart Failure Patients

Daxor Corporation Announces Significant Expansion With Five Hospitals Implementing Its BVA-100 Blood Volume Diagnostic for Heart Failure Patients

Each of the hospital systems represents a significant presence in their regions. Two of the hospitals are part of leading healthcare organizations in New Jersey – one that comprises 17 hospitals, and the other that offers more than 400 sites of care, including hospitals, physician practices, urgent care centers, outpatient ...

ByDaxor Corporation


New Data Shows Heart Failure Treatment Guided by Daxor’s BVA-100 Lowers Hospital Length of Stay by 55%

New Data Shows Heart Failure Treatment Guided by Daxor’s BVA-100 Lowers Hospital Length of Stay by 55%

“Shorter length of hospital stay has an enormous potential for hospital cost savings as hospitals receive a single block payment under DRG rules of reimbursement. All hospital systems are rated under this metric and seeking ways to improve it is one of the reasons we have adopted BVA locally,” stated ...

ByDaxor Corporation


Terumo India Signs a New Strategic Commercial Distribution Partnership with Sensible Medical Innovations

Terumo India Signs a New Strategic Commercial Distribution Partnership with Sensible Medical Innovations

Periodic monitoring through ReDS™ Pro and titration of medicines in heart failure patients can potentially reduce hospitalization rates by 30%. ReDS™ technology has been adapted for medical use from an Israeli military application where it was used to see through walls. ...

BySensible Medical Innovations Ltd.


Endotronix Announces Positive Data from SIRONA 2 in Late-Breaking Clinical Trial Session

Endotronix Announces Positive Data from SIRONA 2 in Late-Breaking Clinical Trial Session

The prospective, multi-center trial met all primary safety and efficacy endpoints and resulted in low rates of HF hospitalization, further validating pulmonary artery (PA) pressure-guided HF management as standard of care for NYHA class III heart failure patients. ...

ByEndotronix, Inc.


Rocket Pharmaceuticals Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

Rocket Pharmaceuticals Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

Shah continued, “We are also pleased to report 100% overall survival at 12-months post-infusion via Kaplan Meier estimate and a statistically significant reduction in all hospitalizations, infection- and inflammatory-related hospitalizations and prolonged hospitalizations for all nine LAD-I patients with three to 24 months of available ...

ByRocket Pharmaceuticals, Inc.


Capricor Therapeutics Reports Topline Results from Phase 2 Exploratory INSPIRE Trial in Severe Hospitalized COVID-19 Patients

Capricor Therapeutics Reports Topline Results from Phase 2 Exploratory INSPIRE Trial in Severe Hospitalized COVID-19 Patients

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics, announced today that its Phase 2, INSPIRE study evaluating a single-dose intravenous infusion of CAP-1002 as a potential treatment option for hospitalized patients with advanced symptoms of COVID-19 met its primary objective of safety. ...

ByCapricor Therapeutics, Inc.


CloudCath Announces $12 Million Series A Financing for Technology Enabling Remote, Real-Time Complication Monitoring for At-Home Dialysis

CloudCath Announces $12 Million Series A Financing for Technology Enabling Remote, Real-Time Complication Monitoring for At-Home Dialysis

For patients undergoing peritoneal dialysis (PD), rates of infection-driven hospitalization are as high as 0.5 hospitalizations per patient year, according to the U.S. ...

ByCloudCath


Research Finds All-Cause Hospitalizations are Nearly Three Times More Likely During a Diabetic Foot Ulcer Episode

Research Finds All-Cause Hospitalizations are Nearly Three Times More Likely During a Diabetic Foot Ulcer Episode

During diabetic foot ulcer episodes-of-care, individuals are 30 times more likely to have a lower limb amputation, eight times more likely to be hospitalized for peripheral vascular disorders, and about two times more likely to be hospitalized for renal failure, congestive heart failure (CHF), pulmonary edema, chronic obstructive pulmonary disease (COPD), or a ...

ByPodimetrics Inc.


New Paper Shows Biostage`s Esophageal Implant Regenerates the Esophagus in Piglets

New Paper Shows Biostage`s Esophageal Implant Regenerates the Esophagus in Piglets

The paper states that current techniques for repairing birth defects in the esophagus, "have significant costs, complication rates, lengthy hospital stays, and significant morbidities. Therefore, the development of novel approaches that bridge a primary long gap…are highly desired." ...

ByHarvard Apparatus Regenerative Technology, Inc. formely known as Biostage, Inc.


The Hitchhiker’s Guide to Survival Analysis

The Hitchhiker’s Guide to Survival Analysis

” Survival analysis is a game-changer for a diverse variety of disciplines and areas of research Most experts, however, mistakenly consider survival analysis a tool solely applied to study death and disease, an accurate method to measure relapse of a medical condition, the potential hospitalization of a patient, and the mortality rate in medicine and ...

ByJADBio


MFDS Greenlights VUNO Med-DeepCARS, AI Medical Device for Cardiac Arrest Prediction

MFDS Greenlights VUNO Med-DeepCARS, AI Medical Device for Cardiac Arrest Prediction

VUNO Med®–DeepCARS™ is a breakthrough AI-driven medical device that analyzes the potential risk of cardiac arrest using four primary vital signs: Blood Pressure (diastolic and systolic) Respiratory Rate Heart Rate Body Temperature These data points are collected from the electronic medical record (EMR) of hospitalized ...

ByVuno Inc.


Procyrion Announces Successful First-In-Human Cases in Cardiorenal Syndrome (CRS) Patients with Aortix™ Percutaneous Mechanical Circulatory Support Device

Procyrion Announces Successful First-In-Human Cases in Cardiorenal Syndrome (CRS) Patients with Aortix™ Percutaneous Mechanical Circulatory Support Device

This negative cycle causes a downward spiral in patients, leading to increased mortality and high re-admission rates. We are excited about Aortix’s potential to disrupt the harmful CRS cycle through its simultaneous cardiac unloading and enhancement of renal ...

ByProcyrion, Inc.


Ground-breaking New Medical Device Saving Lives and Resources During Pandemic

Ground-breaking New Medical Device Saving Lives and Resources During Pandemic

It’s thanks to the world’s first non-invasive lung function monitor, the MediPines AGM100®, developed in California, tested at University of British Columbia and Stevenson Memorial Hospital, and approved for use in Canada. Hospitals are reporting a dramatic decline in ICU admission rates and hospitalized COVID-19 ...

ByMediPines


Abionic launches first Covid-19 severity test to triage patients quickly and accurately

Abionic launches first Covid-19 severity test to triage patients quickly and accurately

The cSOFA score (Covid Sequential Organ Failure Assessment) measures the likelihood of clinical deterioration in Covid-19 patients, enabling triage and assignment to the general ward or intensive care units (ICU) upon admission and during the patients’ hospital stay. A low score allows medical decisions to be made on safely discharging patients from the ...

ByAbionic SA


Today`s Jobs Report: Strong Employment Gains but Danger Ahead

Today`s Jobs Report: Strong Employment Gains but Danger Ahead

In June, employment increased by 4.8 million, with most of the gains coming from retail, leisure, and hospitality. The unemployment rate dropped to 11.1 percent, but the true rate, after adjusting for the misclassification error, is 12.3 percent. ...

ByThe Conference Board Inc


CadiacSense unveils Its business model towards beginning of sales in 2020

CadiacSense unveils Its business model towards beginning of sales in 2020

CardiacSense’s wristwatch measures, among other indices, body temperature, respiratory rate, heart rate, blood pressure and blood oxygen saturation, and detects cardiac arrhythmias and cardiac arrest at a unique accuracy level equivalent to ECG, and is the only medical wristwatch of its kind which was successfully clinically tested in ...

ByCardiacSense


Endotronix Enrolls First Patient in SIRONA II CE Mark Trial

Endotronix Enrolls First Patient in SIRONA II CE Mark Trial

Wilfried Mullens enrolled the first SIRONA II trial patient at the Hospital Oost-Limburg in Genk, Belgium. An investigator in the SIRONA I First-in-Human study, Prof. ...

ByEndotronix, Inc.


Restech announces the clinical validation of the Resmon Pro Diary to remotely monitor COPD at home.

Restech announces the clinical validation of the Resmon Pro Diary to remotely monitor COPD at home.

Using the RESMON PRO DIARY (the home version of the well proven, hospital, clinical unit, the RESMON PRO FULL), 312 patients from 5 different European countries have been successfully monitored for 9 months and their treatment adjusted according to the alerts automatically sent by the device to the clinical staff. This approach significantly reduced the duration and frequency of ...

ByRestech Srl


Safety and Effectiveness of BioTrace Medical’s Tempo® Lead Further Demonstrated in Multi-Center Analysis of More Than 200 Cardiac Procedures

Safety and Effectiveness of BioTrace Medical’s Tempo® Lead Further Demonstrated in Multi-Center Analysis of More Than 200 Cardiac Procedures

Procedures were performed at five prestigious U.S. centers: NewYork-Presbyterian/Columbia University Medical Center, University of Michigan Health Center, Riverside Methodist Hospital/OhioHealth, Intermountain Medical Center, and Yale New Haven Hospital. ...

ByBioTrace Medical Inc


IlluminOss Medical Granted FDA Marketing Clearance for the IlluminOss Bone Stabilization System

IlluminOss Medical Granted FDA Marketing Clearance for the IlluminOss Bone Stabilization System

” Surgeons’ experiences with the product in the international markets have reported smaller incisions, shorter procedural times, faster return to patient daily living activities, with reduced hospital stays and lower complication rates for patients. “The IlluminOss System has significantly changed the way we are able to approach the treatment ...

ByIlluminOss Medical, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT